A Shifting Landscape This morning, you woke up with a mysterious rash. You inspect it, assess your symptoms, ponder it, and then, if you’re like the vast majority of Americans … you Google it. With the internet at your fingertips, information comes at you fast and furious. And with the rise of user-created content on […]
The unbalanced playing field between pharmaceutical manufacturers and telemedicine sites selling versions of approved drugs is finally being addressed in Congress. Congress acts on telemedicine drug advertising as senators push for FDA oversight. A number of large telemedicine direct sell sites have emerged in recent years. These sites diagnose, prescribe, and ship versions of popular […]
Although Google delayed the full phase-out of third-party cookies in Chrome, the digital marketing landscape is still evolving toward a cookieless future. Pharma marketers should utilize this time to refocus on first-party data activation as third-party cookies become less relevant and less reliable. The 2024 Adobe Cookieless Research Report found that nearly half of the […]
One of the things we do at DTC Perspectives is speculate on the future of DTC. No time in DTC history has been as uncertain as now with the Kennedy confirmation. One thing we have learned about the second Trump term is nothing can be ruled out. The idea of incrementalism in policy adjustments is […]